Safety and Efficacy of an Attenuated Vaccine Against Severe Rotavirus Gastroenteritis

This study, published in the New England Journal of Medicine, evaluated the safety and efficacy of GSK’s rotavirus vaccine (Rotarix®), with a focus on determining risk of intussusception.

Author(s): Ruiz-Palacios G, Pérez-Schael I, Velázquez F, et al.

Published: 2006

  • Visit web page (English)

    (Located at content.nejm.org)

    Citation: Ruiz-Palacios G, Pérez-Schael I, Velázquez F, et al. Safety and Efficacy of an Attenuated Vaccine Against Severe Rotavirus Gastroenteritis. New England Journal of Medicine. 2006;354(1):11-22.

  • Download file (French)

    Also known as: Sécurité et efficacité d’un vaccin atténué contre la gastro-entérite grave à rotavirus

    244 KB PDF

  • Download file (Russian)

    Also known as: Безопасность и эффективность живой ослабленной антиротавирусной вакцины

    253 KB PDF

  • Download file (Spanish)

    Also known as: Seguridad y eficacia de una vacuna atenuada frente a la gastroenteritis grave por rotavirus

    233 KB PDF